14:10 ET SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Regulus Therapeutics Inc. - RGLS

prnewswire
2025.04.30 18:11
portai
I'm PortAI, I can summarize articles.

Monteverde & Associates PC is investigating the proposed merger of Regulus Therapeutics Inc. (NASDAQ: RGLS) with Novartis AG. The merger includes an initial payment of $7.00 per share and a potential additional $7.00 per share contingent on regulatory approval. The firm, recognized for recovering millions for shareholders, offers free consultations for those concerned about their investments in Regulus.